Association Between Fever and Antibody Titer Trends After a Third Dose of the mRNA-1273 Vaccine

• Naomi Matsumoto,
• Tomoka Kadowaki,
• Rumi Matsuo,
• Ayako Sasaki,
• Chikara Miyaji,
• Chigusa Higuchi,
• Masanori Nakayama,
• Yasue Sakurada,
• Hideharu Hagiya,
• Soshi Takao,
• Fumio Otsuka,
• Takashi Yorifuji

Affiliations

Naomi Matsumoto

Department of Epidemiology, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan

Tomoka Kadowaki

Department of Epidemiology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan

Rumi Matsuo

Department of Epidemiology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan

Ayako Sasaki

Department of Epidemiology, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan

Chikara Miyaji

Department of Epidemiology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan

Chigusa Higuchi

Okayama University Health Service Center, Okayama, Japan

Masanori Nakayama

Office of Innovative Medicine, Organization for Research Strategy and Development, Okayama University, Okayama, Japan

Yasue Sakurada

Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan

Hideharu Hagiya

Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan

Soshi Takao

Department of Epidemiology, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan

Fumio Otsuka

Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan

Takashi Yorifuji

Department of Epidemiology, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan